Cited 11 time in
Assessment of variables associated with prolonged admission duration in children with Mycoplasma pneumoniae pneumonia
| DC Field | Value | Language |
|---|---|---|
| dc.contributor.author | Sung, Myongsoon | - |
| dc.contributor.author | Roh, Eui Jeong | - |
| dc.contributor.author | Lee, Eun Sil | - |
| dc.contributor.author | Lee, Ji Young | - |
| dc.contributor.author | Kim, Hyo-Bin | - |
| dc.contributor.author | Ahn, Youngmin | - |
| dc.contributor.author | Eun, Byung Wook | - |
| dc.contributor.author | Kim, Ja Kyoung | - |
| dc.contributor.author | Kim, Hyoung Young | - |
| dc.contributor.author | Jung, Sung-Su | - |
| dc.contributor.author | Kim, Minji | - |
| dc.contributor.author | Kang, Eun Kyeong | - |
| dc.contributor.author | Yang, Eun-Ae | - |
| dc.contributor.author | Lee, Soo Jin | - |
| dc.contributor.author | Park, Yang | - |
| dc.contributor.author | Seo, Ju-Hee | - |
| dc.contributor.author | Lee, Eun | - |
| dc.contributor.author | Yang, Eun Seok | - |
| dc.contributor.author | Cho, Hyung Min | - |
| dc.contributor.author | Shin, Meeyong | - |
| dc.contributor.author | Chung, Hai Lee | - |
| dc.contributor.author | Jang, Yoon Young | - |
| dc.contributor.author | Choi, Bong Seok | - |
| dc.contributor.author | Kim, Hyeona | - |
| dc.contributor.author | Jung, Jin-A | - |
| dc.contributor.author | You, Seung Taek | - |
| dc.contributor.author | Lee, Mi-Hee | - |
| dc.contributor.author | Kim, Jin Tack | - |
| dc.contributor.author | Kim, Bong Seong | - |
| dc.contributor.author | Hwang, Yoon Ha | - |
| dc.contributor.author | Shim, Jung Yeon | - |
| dc.contributor.author | Yang, Hyeon-Jong | - |
| dc.contributor.author | Han, Man Yong | - |
| dc.contributor.author | Yew, Hae Young | - |
| dc.contributor.author | Kim, Dong Hyeok | - |
| dc.contributor.author | Jeong, Sang Oun | - |
| dc.contributor.author | Whang, Kyujam | - |
| dc.contributor.author | Lee, Eunjoo | - |
| dc.contributor.author | Jeon, You Hoon | - |
| dc.contributor.author | Chung, Eun Hee | - |
| dc.date.accessioned | 2023-04-27T08:40:53Z | - |
| dc.date.available | 2023-04-27T08:40:53Z | - |
| dc.date.issued | 2022-11 | - |
| dc.identifier.issn | 1752-6981 | - |
| dc.identifier.issn | 1752-699X | - |
| dc.identifier.uri | https://scholarworks.dongguk.edu/handle/sw.dongguk/2273 | - |
| dc.description.abstract | Introduction: Macrolide-resistant Mycoplasma pneumoniae (MRMP) has become prevalent in children. This study investigated the clinical and laboratory variables of MRMP and macrolide-sensitive M. pneumoniae (MSMP) and identified factors associated with prolonged hospital admission in children. Methods: A prospective multicenter study was conducted in 1063 children <18 years old in July 2018-June 2020. The 454 had a positive M. pneumoniae polymerase chain reaction assay. Results: Most subjects had MRMP (78.4%), and all mutated strains had the A2063G transition. We defined MRMP* (n = 285) as MRMP pneumonia requiring admission and MSMP* (n = 72) as MSMP pneumonia requiring admission. Patients with MRMP pneumonia were older, more likely to have segmental/lobar pneumonia, and had more febrile days than those with MSMP pneumonia. C-reactive protein (CRP), lactate dehydrogenase (LDH), and percentage neutrophils were more strongly associated with MRMP* than MSMP* groups. Percentage neutrophils, CRP, and alanine aminotransferase significantly changed between admission and follow-up measurements in patients with MRMP* (P < 0.05). The duration of admission positively correlated with the number of febrile days after initiation of antibiotic medication and laboratory variables (white blood cell count, CRP, and aspartate aminotransferase [AST]) (P < 0.05). Random forest analysis indicated that the number of febrile days after initiation of antibiotic medication, AST, and percentage neutrophils at admission was over five. Conclusions: This study indicated that children with M. pneumoniae pneumonia with a higher number of febrile days after initiation of antibiotic medication, AST, and percentage neutrophils at admission were more likely to have prolonged admission duration. | - |
| dc.format.extent | 12 | - |
| dc.language | 영어 | - |
| dc.language.iso | ENG | - |
| dc.publisher | John Wiley & Sons, Ltd. | - |
| dc.title | Assessment of variables associated with prolonged admission duration in children with Mycoplasma pneumoniae pneumonia | - |
| dc.type | Article | - |
| dc.publisher.location | 미국 | - |
| dc.identifier.doi | 10.1111/crj.13549 | - |
| dc.identifier.scopusid | 2-s2.0-85139402247 | - |
| dc.identifier.wosid | 000864613600001 | - |
| dc.identifier.bibliographicCitation | The Clinical Respiratory Journal, v.16, no.11, pp 756 - 767 | - |
| dc.citation.title | The Clinical Respiratory Journal | - |
| dc.citation.volume | 16 | - |
| dc.citation.number | 11 | - |
| dc.citation.startPage | 756 | - |
| dc.citation.endPage | 767 | - |
| dc.type.docType | Article | - |
| dc.description.isOpenAccess | Y | - |
| dc.description.journalRegisteredClass | scie | - |
| dc.description.journalRegisteredClass | scopus | - |
| dc.relation.journalResearchArea | Respiratory System | - |
| dc.relation.journalWebOfScienceCategory | Respiratory System | - |
| dc.subject.keywordPlus | COMMUNITY-ACQUIRED PNEUMONIA | - |
| dc.subject.keywordPlus | MACROLIDE RESISTANCE | - |
| dc.subject.keywordPlus | INFECTIONS | - |
| dc.subject.keywordPlus | THERAPY | - |
| dc.subject.keywordAuthor | aspartate aminotransferase | - |
| dc.subject.keywordAuthor | children | - |
| dc.subject.keywordAuthor | M. pneumoniae | - |
| dc.subject.keywordAuthor | macrolide-resistant M. pneumoniae | - |
| dc.subject.keywordAuthor | neutrophil portion | - |
Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.
30, Pildong-ro 1-gil, Jung-gu, Seoul, 04620, Republic of Korea+82-2-2260-3114
Copyright(c) 2023 DONGGUK UNIVERSITY. ALL RIGHTS RESERVED.
Certain data included herein are derived from the © Web of Science of Clarivate Analytics. All rights reserved.
You may not copy or re-distribute this material in whole or in part without the prior written consent of Clarivate Analytics.
